Comparison of the Efficacy of Two Routes of Administration of Human Amniotic Epithelial Cells in Cell Therapy of Acute Hepatic Insufficiency.
acute liver failure
cell biodistribution
experimental models of hepatotoxicity
galactosoamine
human amniotic epithelial cells
intraperitoneal injection
intravenous injection
stem cell therapy
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
08 Apr 2024
08 Apr 2024
Historique:
received:
15
03
2024
revised:
02
04
2024
accepted:
03
04
2024
medline:
27
4
2024
pubmed:
27
4
2024
entrez:
27
4
2024
Statut:
epublish
Résumé
The route of administration of implanted cells may affect the outcome of cell therapy by directing cell migration to the damaged site. However, the question of the relationship between the route of administration, the efficacy of colonisation of a given organ, and the efficacy of cell therapy has not been resolved. The aim of the study was to localise transplanted intravenously and intraperitoneally human amniotic epithelial cells (hAECs) in the tissues of mice, both healthy and injured, in an animal experimental model of acute liver failure (ALF). Mice intoxicated with D-Galactosamine (D-GalN) at a dose of 150 mg/100 g body weight received D-GalN alone or with a single dose of hAECs administered by different routes. Subsequently, at 6, 24, and 72 h after D-GaIN administration and at 3, 21, and 69 h after hAEC administration, lungs, spleen, liver, and blood were collected from recipient mice. The degree of liver damage and regeneration was assessed based on biochemical blood parameters, histopathological evaluation (H&E staining), and immunodetection of proliferating (Ki67
Identifiants
pubmed: 38675436
pii: ph17040476
doi: 10.3390/ph17040476
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical University of Silesia in Katowice
ID : PCN-2-003/K/1/I, PCN-2-005/N/0/O, PCN-2-048/N/2/I
Organisme : National Science Center
ID : 2021/41/N/NZ7/00355